GE Healthcare has secured an expansion of its existing $35 million contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, to fast-track development of AI-enabled point of care ultrasound solutions specifically designed for trauma and critical care settings. The enhanced funding will support advanced algorithm refinement, real world validation in high-acuity environments, and regulatory pathways to bring faster, more accurate trauma diagnostics to emergency departments, field hospitals, and disaster response scenarios.
Glimpse:
The contract expansion, announced on January 26, 2026, builds on GE’s prior BARDA collaboration by adding resources for next-generation AI models that improve detection of life threatening conditions such as pneumothorax, hemoperitoneum, pericardial effusion, and vascular injury during trauma assessment. The technology leverages GE’s Vscan Air and other portable ultrasound platforms, combining edge AI processing with cloud-based learning to deliver real time guidance and decision support for frontline clinicians potentially reducing time to diagnosis and improving outcomes in mass casualty and austere environments.
GE Healthcare has received an expanded $35 million contract award from BARDA (Biomedical Advanced Research and Development Authority) to accelerate the development and validation of AI-powered ultrasound tools tailored for trauma and emergency care. The announcement, made on January 26, 2026, extends GE’s ongoing partnership with BARDA under the DRIVe (Division of Research, Innovation, and Ventures) initiative, which focuses on innovative technologies to strengthen U.S. health security preparedness.
The expanded scope will fund refinement of GE’s existing AI algorithms and the creation of new models optimised for rapid trauma assessment. These include automated detection and classification of critical findings such as pneumothorax (collapsed lung), hemoperitoneum (abdominal bleeding), pericardial effusion (heart tamponade), and vascular injuries conditions that require immediate intervention in trauma patients. The AI will provide real-time visual overlays, confidence scores, and prioritised alerts directly on GE’s portable ultrasound devices (including Vscan Air and Venue family systems), enabling faster decision-making even for less experienced operators in high-pressure settings.
The technology emphasises edge computing for offline capability in austere or disaster environments, while also supporting cloud connectivity for continuous model improvement through federated learning from anonymised clinical data. BARDA’s support includes requirements for rigorous validation in simulated and real-world trauma scenarios, multi-site clinical studies, and alignment with FDA pathways for emergency use authorisation and eventual full clearance.
Roland Rott, President and CEO of GE Healthcare’s Ultrasound business, stated: “Trauma care demands speed, accuracy, and reliability especially in the critical first minutes. By expanding our collaboration with BARDA, we’re accelerating AI tools that empower clinicians to make faster, more confident decisions when every second counts whether in a busy ER, on the battlefield, or during a mass casualty event.”
The project aligns with BARDA’s mission to advance medical countermeasures against public health emergencies, including mass casualty incidents, natural disasters, and acts of terrorism. GE Healthcare’s portable ultrasound platforms are already widely used in emergency and trauma settings globally, and the addition of trauma specific AI is expected to further enhance their utility in pre-hospital, austere, and resource limited environments.
The expanded contract includes milestones for algorithm performance, usability testing with trauma surgeons and emergency physicians, and simulation-based validation. Successful completion could lead to broader deployment across U.S. trauma centres, military health systems, and international disaster response organisations.
“In trauma, the difference between life and death can come down to seconds. AI-enabled ultrasound gives clinicians clearer, faster insights exactly when they need them most helping save lives in the most critical moments.”
By
HB Team
Related News
